about
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.Miyabeacin: A new cyclodimer presents a potential role for willow in cancer therapySelective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLProteomics of SARS-CoV-2-infected host cells reveals therapy targetsSARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
P50
description
researcher
@en
wetenschapper
@nl
name
Jindrich Cinatl
@en
Jindrich Cinatl
@nl
type
label
Jindrich Cinatl
@en
Jindrich Cinatl
@nl
prefLabel
Jindrich Cinatl
@en
Jindrich Cinatl
@nl
P31
P496
0000-0002-6744-2087